BURLINGTON, Mass.--(BUSINESS WIRE)--Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that its TVC Imaging System™ for the true vessel characterization of coronary artery disease will be highlighted in 10 poster and oral presentations during the annual Transcatheter Cardiovascular Therapeutics Meeting (TCT 2012). TCT 2012, the world's largest educational meeting specializing in interventional cardiovascular medicine, will be held October 22-26, 2012 at the Miami Beach Convention Center in Miami.
